{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:13:52Z","timestamp":1772331232072,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["5886"],"award-info":[{"award-number":["5886"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Women of reproductive age who carry fragile X premutation (PM) alleles have 56 to 200 CGG repeats in the 5\u2032-untranslated region of<jats:italic>FMR1<\/jats:italic>gene are at increased risk for producing children with intellectual disabilities (ID) or autism spectrum disorders (ASD) due to expansion of PM alleles to full mutation alleles (&gt;\u2009200 repeats) during maternal transmission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In present study fragile X PM carrier screening was performed in total 808 women who were consulting primary health care centers for preconception care in Khyber Pakhtunkhwa region of Pakistan between April, 2018 and December, 2020. Polymerase chain reaction (PCR) was performed for detection of PM carrier women and the CGG repeats number was confirmed by Southern blotting and capillary electrophoresis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence rate for PM carriers among preconception women was found to be 0.7% that was contributed by 0.5% women in risk group (RG1) with family history of ID and 0.2% in risk group 2 (RG2) with family history of ASD. PM carrier women had at least one affected child or sibling. In addition, the preconception women with<jats:italic>FMR1<\/jats:italic>PM alleles were found to be at increased risk for primary ovary insufficiency (RG1:<jats:italic>P<\/jats:italic>\u2009=\u20090.0265, RG2:<jats:italic>P<\/jats:italic>\u2009=\u20090.0389), postpartum depression (RG1:<jats:italic>P<\/jats:italic>\u2009=\u20090.0240, RG2:<jats:italic>P<\/jats:italic>\u2009=\u20090.0501) and neuropsychiatric disorders (RG1:<jats:italic>P<\/jats:italic>\u2009=\u20090.0389, RG2:<jats:italic>P<\/jats:italic>\u2009=\u20090.0432).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Current study provides first evidence of fragile X PM carrier screening in Pakistani preconception women in primary care consultation. Findings of current study may help to improve preconception care and to reduce burden of fragile X associated disorders in our population.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12905-022-01632-1","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:38:34Z","timestamp":1646401114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fragile X premutation carrier screening in Pakistani preconception women in primary care consultation"],"prefix":"10.1186","volume":"22","author":[{"given":"Neelam","family":"Meraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleema","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humaira","family":"Jadoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irba","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musarrat","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzadi","family":"Neelam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-0666","authenticated-orcid":false,"given":"Shamim","family":"Saleha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"4","key":"1632_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1399-0004.2009.01317.x","volume":"77","author":"JE Hunter","year":"2010","unstructured":"Hunter JE, Rohr JK, Sherman SL. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet. 2010;77(4):374\u201381.","journal-title":"Clin Genet"},{"issue":"1","key":"1632_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. Fragile X syndrome. Nat Rev Dis Primers. 2017;3(1):1\u20139.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"1632_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/gim.2013.61","volume":"15","author":"KG Monaghan","year":"2013","unstructured":"Monaghan KG, Lyon E, Spector EB. ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics. Genet Med. 2013;15(7):575\u201386.","journal-title":"Genet Med"},{"issue":"4","key":"1632_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2353\/jmoldx.2009.080173","volume":"11","author":"I Fernandez-Carvajal","year":"2009","unstructured":"Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn. 2009;11(4):324\u20139.","journal-title":"J Mol Diagn"},{"issue":"11","key":"1632_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/GIM.0b013e31818b0c8a","volume":"10","author":"GB Schaefer","year":"2008","unstructured":"Schaefer GB, Mendelsohn NJ. Response to letter by Chodirker and Chudley. Genet Med. 2008;10(11):845.","journal-title":"Genet Med"},{"issue":"7","key":"1632_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","volume":"164","author":"J Hunter","year":"2014","unstructured":"Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J. Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 2014;164(7):1648\u201358.","journal-title":"Am J Med Genet A"},{"key":"1632_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2005","unstructured":"Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20:402.","journal-title":"Hum Reprod."},{"key":"1632_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnmol.2019.00273","volume":"12","author":"JS Retamal","year":"2019","unstructured":"Retamal JS, Ram\u00edrez-Garc\u00eda PD, Shenoy PA, Poole DP, Veldhuis NA. Internalized GPCRs as potential therapeutic targets for the management of pain. Front Mol Neurosci. 2019;12:273.","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"1632_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ejhg.2014.185","volume":"23","author":"V Biancalana","year":"2015","unstructured":"Biancalana V, Glaeser D, McQuaid S, Steinbach P. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet. 2015;23(4):417\u201325.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"1632_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/gme.0b013e31804c793d","volume":"14","author":"JC Gallagher","year":"2007","unstructured":"Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14(3):567\u201371.","journal-title":"Menopause"},{"issue":"6","key":"1632_CR11","first-page":"360","volume":"46","author":"HH Nguyen","year":"2017","unstructured":"Nguyen HH, Milat F, Vincent A. Premature ovarian insufficiency in general practice: meeting the needs of women. Aust Fam Phys. 2017;46(6):360\u20136.","journal-title":"Aust Fam Phys"},{"key":"1632_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","volume":"9","author":"RJ Hagerman","year":"2018","unstructured":"Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-associated neuropsychiatric disorders (FXAND). Front Psychiatry. 2018;9:564.","journal-title":"Front Psychiatry"},{"key":"1632_CR13","doi-asserted-by":"crossref","unstructured":"Kallinen J, Korhonen K, Kortelainen S, Heinonen S, Ryyn\u00e4nen M. Pregnancy outcome in carriers of fragile X. BJOG Int J Obstet Gynaecol. 2000;107(8):969\u201372.","DOI":"10.1111\/j.1471-0528.2000.tb10398.x"},{"issue":"1","key":"1632_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1352\/1944-7558-117.1.1","volume":"117","author":"LE Smith","year":"2012","unstructured":"Smith LE, Barker ET, Seltzer MM, Abbeduto L, Greenberg JS. Behavioral phenotype of fragile X syndrome in adolescence and adulthood. Am J Intellect Dev Disabil. 2012;117(1):1\u20137.","journal-title":"Am J Intellect Dev Disabil"},{"key":"1632_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-4939-9080-1_15","volume-title":"Fragile-X syndrome 2019","author":"M Zafarullah","year":"2019","unstructured":"Zafarullah M, Tassone F. Fragile X-associated tremor\/ataxia syndrome (FXTAS). In: Ben-Yosef D, Mayshar Y, editors. Fragile-X syndrome 2019. New York: Humana Press; 2019. p. 173\u201389."},{"issue":"16","key":"1632_CR16","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","volume":"146","author":"DB Bailey Jr","year":"2008","unstructured":"Bailey DB Jr, Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. 2008;146(16):2060\u20139.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1632_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11689-011-9084-5","volume":"3","author":"R Hagerman","year":"2011","unstructured":"Hagerman R, Au J, Hagerman P. FMR1 premutation and full mutation molecular mechanisms related to autism. J Neurodev Disord. 2011;3(3):211\u201324.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"1632_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0969141313488364","volume":"20","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Kim DJ, Kim SY, Yang JH, Kim MH, Lee SW, Jeong SO, Park SY, Ryu HM. Fragile X carrier screening in Korean women of reproductive age. J Med Screen. 2013;20(1):15\u201320.","journal-title":"J Med Screen"},{"issue":"1","key":"1632_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51726-4","volume":"9","author":"CC Hung","year":"2019","unstructured":"Hung CC, Lee CN, Wang YC, Chen CL, Lin TK, Su YN, Lin MW, Kang J, Tai YY, Hsu WW, Lin SY. Fragile X syndrome carrier screening in pregnant women in Chinese Han population. Sci Rep. 2019;9(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"21","key":"1632_CR20","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1002\/ajmg.a.31993","volume":"143","author":"J Zhao","year":"2007","unstructured":"Zhao J, Hu Q, Chen Y, Luo S, Bao L, Xu Y. A novel missense mutation in the paired domain of human PAX9 causes oligodontia. Am J Med Genet A. 2007;143(21):2592\u20137.","journal-title":"Am J Med Genet A"},{"issue":"8","key":"1632_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","volume":"7","author":"S Sherman","year":"2005","unstructured":"Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005;7(8):584\u20137.","journal-title":"Genet Med"},{"key":"1632_CR22","doi-asserted-by":"crossref","unstructured":"on Genetics GC. ACOG Committee opinion no. 469: carrier screening for fragile X syndrome. Obstet Gynecol. 2010;116(4):1008\u201310.","DOI":"10.1097\/AOG.0b013e3181fae884"},{"issue":"1","key":"1632_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","volume":"10","author":"F Tassone","year":"2008","unstructured":"Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn. 2008;10(1):43\u20139.","journal-title":"J Mol Diagn"},{"issue":"2","key":"1632_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ajmg.a.30191","volume":"129","author":"S Zeesman","year":"2004","unstructured":"Zeesman S, Zwaigenbaum L, Whelan DT, Hagerman RJ, Tassone F, Taylor SA. Paternal transmission of fragile X syndrome. Am J Med Genet A. 2004;129(2):184\u20139.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1632_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12687-016-0262-8","volume":"7","author":"AD Archibald","year":"2016","unstructured":"Archibald AD, Hickerton CL, Wake SA, Jaques AM, Cohen J, Metcalfe SA. \u201cIt gives them more options\u201d: preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare. J Community Genet. 2016;7(2):159\u201371.","journal-title":"J Community Genet"},{"issue":"2","key":"1632_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/367713","volume":"72","author":"SL Nolin","year":"2003","unstructured":"Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Br\u00f6ndum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003;72(2):454\u201364.","journal-title":"Am J Hum Genet"},{"issue":"R1","key":"1632_CR27","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1093\/hmg\/ddq166","volume":"19","author":"D Garcia-Arocena","year":"2010","unstructured":"Garcia-Arocena D, Hagerman PJ. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet. 2010;19(R1):R83\u20139.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1632_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M","volume":"20","author":"R Pesso","year":"2000","unstructured":"Pesso R, Berkenstadt M, Cuckle H, Gak E, Peleg L, Frydman M, Barkai G. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn. 2000;20(8):611\u20134.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1632_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/ajmg.a.32725","volume":"149","author":"K Acharya","year":"2009","unstructured":"Acharya K, Ross LF. Fragile X screening: attitudes of genetic health professionals. Am J Med Genet A. 2009;149(4):626\u201332.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"1632_CR30","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/gim.2017.67","volume":"19","author":"SA Metcalfe","year":"2017","unstructured":"Metcalfe SA, Martyn M, Ames A, Anderson V, Archibald AD, Couns GD, Carter R, Cohen J, Cotter M, GenCouns M, Dang W. Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening. Genet Med. 2017;19(12):1346\u201355.","journal-title":"Genet Med"},{"issue":"1","key":"1632_CR31","doi-asserted-by":"publisher","first-page":"S578","DOI":"10.1016\/j.ajog.2018.11.917","volume":"220","author":"KJ Taber","year":"2019","unstructured":"Taber KJ, Beauchamp K, Lazarin G, Muzzey D, Arjunan A, Goldberg J. 893: Clinical utility of expanded carrier screening: Results-guided actionability and outcomes. Am J Obstet Gynecol. 2019;220(1):S578\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"1632_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/pd.1815","volume":"27","author":"M Berkenstadt","year":"2007","unstructured":"Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G. Preconceptional and prenatal screening for fragile X syndrome: Experience with 40 000 tests. Prenat Diagn. 2007;27(11):991\u20134.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1632_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/01.GIM.0000159898.90221.D3","volume":"7","author":"A Cronister","year":"2005","unstructured":"Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet Med. 2005;7(4):246\u201350.","journal-title":"Genet Med"},{"issue":"6","key":"1632_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10897-012-9524-8","volume":"21","author":"B Finucane","year":"2012","unstructured":"Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. J Genet Couns. 2012;21(6):752\u201360.","journal-title":"J Genet Couns"},{"issue":"2","key":"1632_CR35","first-page":"110","volume":"23","author":"YK Cheng","year":"2017","unstructured":"Cheng YK, Lin CS, Kwok YK, Chan YM, Lau TK, Leung TY, Choy KW. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis. Hong Kong Med J. 2017;23(2):110\u20136.","journal-title":"Hong Kong Med J"},{"issue":"2","key":"1632_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1086\/321974","volume":"69","author":"H Toledano-Alhadef","year":"2001","unstructured":"Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, Taub E, Halpern GJ, Ginott N, Shohat M. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet. 2001;69(2):351\u201360.","journal-title":"Am J Hum Genet"},{"key":"1632_CR37","doi-asserted-by":"crossref","unstructured":"Alfaro Arenas R, Rosell Andreo J, Heine Su\u00f1er D, Group for the study of FXS in the Balearic Islands. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands. Am J Med Genet Part B Neuropsychiatr Genet. 2016;171(8):1023\u201331.","DOI":"10.1002\/ajmg.b.32470"},{"key":"1632_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fneur.2017.00254","volume":"8","author":"M Niu","year":"2017","unstructured":"Niu M, Han Y, Dy AB, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. Fragile X syndrome: prevalence, treatment, and prevention in China. Front Neurol. 2017;8:254.","journal-title":"Front Neurol"},{"issue":"7","key":"1632_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1651-2227.2002.tb03336.x","volume":"91","author":"A Bashir","year":"2002","unstructured":"Bashir A, Yaqoob M, Ferngren H, Gustavson KH, Rydelius PA, Ansari T, Zaman S. Prevalence and associated impairments of mild mental retardation in six-to ten-year old children in Pakistan: a prospective study. Acta Paediatr. 2002;91(7):833\u20137.","journal-title":"Acta Paediatr"},{"key":"1632_CR40","unstructured":"Imran N, Bhatti MR, Anwar A, Najmi F, Haider II. Children's Mental Health: pattern of referral, distribution of disorders and service use in child psychiatry outpatient setting. Pak J Med Sci. 2012;28(1):22-26"},{"issue":"5","key":"1632_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1192\/pb.bp.108.020487","volume":"33","author":"A Tareen","year":"2009","unstructured":"Tareen A, Mirza I, Minhas A, Minhas F, Rahman A. Developing a child and adolescent mental health service in a low-income country: a global partnership model. Psychiatr Bull. 2009;33(5):181\u20133.","journal-title":"Psychiatr Bull"},{"key":"1632_CR42","doi-asserted-by":"crossref","unstructured":"Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. In: Seminars in reproductive medicine 2011 Jul, vol 29, no. 04, pp 299\u2013307. \u00a9 Thieme Medical Publishers.","DOI":"10.1055\/s-0031-1280915"},{"issue":"1","key":"1632_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1866-1955-6-30","volume":"6","author":"AC Wheeler","year":"2014","unstructured":"Wheeler AC, Bailey DB Jr, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Mil\u00e0 M, Olichney JM, Rodriguez-Revenga L, Sherman S, Smith L. Associated features in females with an FMR1 premutation. J Neurodev Disord. 2014;6(1):1\u20134.","journal-title":"J Neurodev Disord"},{"issue":"8","key":"1632_CR44","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1093\/humrep\/der146","volume":"26","author":"MA Spath","year":"2011","unstructured":"Spath MA, Feuth TB, Allen EG, Smits AP, Yntema HG, van Kessel AG, Braat DD, Sherman SL, Thomas CM. Intra-individual stability over time of standardized anti-M\u00fcllerian hormone in FMR1 premutation carriers. Hum Reprod. 2011;26(8):2185\u201391.","journal-title":"Hum Reprod"},{"issue":"4","key":"1632_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","volume":"68","author":"CK Welt","year":"2008","unstructured":"Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008;68(4):499\u2013509.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"1632_CR46","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/humrep\/dem148","volume":"22","author":"EG Allen","year":"2007","unstructured":"Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22(8):2142\u201352.","journal-title":"Hum Reprod"},{"issue":"1","key":"1632_CR47","first-page":"72","volume":"9","author":"RW Obadia","year":"2013","unstructured":"Obadia RW, Iosif AM, Seritan AL. Postpartum depression in women with the FMR1 premutation. Curr Psychiatry Rev. 2013;9(1):72\u20137.","journal-title":"Curr Psychiatry Rev."},{"issue":"1","key":"1632_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajmg.b.30786","volume":"150","author":"JE Roberts","year":"2009","unstructured":"Roberts JE, Bailey DB Jr, Mankowski J, Ford A, Sideris J, Weisenfeld LA, Heath TM, Golden RN. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet. 2009;150(1):130\u20139.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"1632_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10519-005-2792-4","volume":"35","author":"EG Allen","year":"2005","unstructured":"Allen EG, Sherman S, Abramowitz A, Leslie M, Novak G, Rusin M, Scott E, Letz R. Examination of the effect of the polymorphic CGG repeat in the FMR1 gene on cognitive performance. Behav Genet. 2005;35(4):435\u201345.","journal-title":"Behav Genet"},{"issue":"9","key":"1632_CR50","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","volume":"69","author":"JS Adams","year":"2007","unstructured":"Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C. Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS). Neurology. 2007;69(9):851\u20139.","journal-title":"Neurology"},{"issue":"8","key":"1632_CR51","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/ajmg.b.31237","volume":"156","author":"A Hamlin","year":"2011","unstructured":"Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet. 2011;156(8):923\u20138.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"1632_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/cge.12249","volume":"86","author":"SM Summers","year":"2014","unstructured":"Summers SM, Cogswell J, Goodrich JE, Mu Y, Nguyen DV, Brass SD, Hagerman RJ. Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation. Clin Genet. 2014;86(2):181\u20134.","journal-title":"Clin Genet"},{"issue":"4","key":"1632_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.6000\/2292-2598.2019.07.04.1","volume":"7","author":"TI Winarni","year":"2019","unstructured":"Winarni TI, Sumekar TA, Wibowo S, Hagerman RJ, Faradz SM. Premutation allele combined with caregiver distress factor increase the risk of depression in fragile X carriers: Indonesia setting. J Intellect Disabil Diagn Treat. 2019;7(4):200\u20138.","journal-title":"J Intellect Disabil Diagn Treat"},{"issue":"1","key":"1632_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bandc.2013.02.009","volume":"82","author":"AM Sterling","year":"2013","unstructured":"Sterling AM, Mailick M, Greenberg J, Warren SF, Brady N. Language dysfluencies in females with the FMR1 premutation. Brain Cogn. 2013;82(1):84\u20139.","journal-title":"Brain Cogn"},{"issue":"6","key":"1632_CR55","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/ajmg.b.32070","volume":"159","author":"M Losh","year":"2012","unstructured":"Losh M, Klusek J, Martin GE, Sideris J, Parlier M, Piven J. Defining genetically meaningful language and personality traits in relatives of individuals with fragile X syndrome and relatives of individuals with autism. Am J Med Genet B Neuropsychiatr Genet. 2012;159(6):660\u20138.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"1632_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/WAD.0b013e31811ec130","volume":"21","author":"JT Al-Hinti","year":"2007","unstructured":"Al-Hinti JT, Nagan N, Harik SI. Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure. Alzheimer Dis Assoc Disord. 2007;21(3):262\u20134.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"1632_CR57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ana.23933","volume":"74","author":"JC Yang","year":"2013","unstructured":"Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013;74(2):275\u201383.","journal-title":"Ann Neurol"},{"issue":"1","key":"1632_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0165025411406857","volume":"36","author":"SL Hartley","year":"2012","unstructured":"Hartley SL, Seltzer MM, Hong J, Greenberg JS, Smith L, Almeida D, Coe C, Abbeduto L. Cortisol response to behavior problems in FMR1 premutation mothers of adolescents and adults with fragile X syndrome: a diathesis-stress model. Int J Behav Dev. 2012;36(1):53\u201361.","journal-title":"Int J Behav Dev"},{"issue":"1","key":"1632_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1399-0004.2010.01448.x","volume":"78","author":"W Chonchaiya","year":"2010","unstructured":"Chonchaiya W, Nguyen DV, Au J, Campos L, Berry-Kravis EM, Lohse K, Mu Y, Utari A, Hervey C, Wang L, Sorensen P. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet. 2010;78(1):38\u201346.","journal-title":"Clin Genet"},{"issue":"5","key":"1632_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12311-016-0805-x","volume":"15","author":"R Lozano","year":"2016","unstructured":"Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Aging in fragile X premutation carriers. Cerebellum. 2016;15(5):587\u201394.","journal-title":"Cerebellum"},{"issue":"6","key":"1632_CR61","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/cge.12109","volume":"84","author":"J Au","year":"2013","unstructured":"Au J, Akins RS, Berkowitz-Sutherland L, Tang HT, Chen Y, Boyd A, Tassone F, Nguyen DV, Hagerman R. Prevalence and risk of migraine headaches in adult fragile X premutation carriers. Clin Genet. 2013;84(6):546\u201351.","journal-title":"Clin Genet"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01632-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01632-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:39:27Z","timestamp":1700307567000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01632-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1632"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01632-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of present study was obtained from the Research and Ethical Committee and Advanced Studies Research Board (ASRB) of Kohat University of Science and Technology (KUST), Kohat, Khyber Pakhtunkhwa, Pakistan. Written informed consent was obtained from all women for participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}